Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2012-09-26
Original SEC Filing: Click here

---

Webplus: SVA/20120926/6-K/2_EX-99.1/000.htm SEC Original: v324436_ex99-1.htm
Sinovac Receives Beijing CDC Tender Award to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, announced today that it has been selected by the Beijing Centers for Disease Control and Prevention (Beijing CDC) to supply seasonal influenza vaccine to the citizens of Beijing. Dr. Weidong Yin, Chairman, President

---

---

Webplus: SVA/20120926/6-K/3_EX-99.2/000.htm SEC Original: v324436_ex99-2.htm
Sinovac Biotech Receives GMP Certification for Mumps Vaccine Production Facility Sinovac Biotech Ltd. (SVA), a leading China-based vaccine manufacturer, announced today that it has received GMP certification from the China State Food and Drug Administration (SFDA) for the Company’s dedicated mumps vaccine production plant at its Sinovac Dalian facility. The SFDA issued a public announcement on September 12, 2012, stating

---

---

Webplus: SVA/20120926/6-K/4_EX-99.3/000.htm SEC Original: v324436_ex99-3.htm
Sinovac Awarded Tenders in Beijing and Shanghai to Supply Inactivated Hepatitis A Vaccine Healive® Under Expanded Immunization Program SVA BEIJING, Sept. 25, 2012 — Sinovac Biotech Ltd. ( Mr. Weidong Yin, Chairman, President and CEO of Sinovac, commented, “We are pleased to have been selected as the sole supplier of the inactivated hepatitis A vaccine in prefilled syringe in both

---

---

Webplus: SVA/20120926/6-K/1/000.htm SEC Original: v324436_6k.htm

---

Company Information:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2012-09-26CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085